This popped up on Twitter as a sponsored link. It's worth reading
The Economics of Healthcare- Blood Cancer - CLL Support
The Economics of Healthcare- Blood Cancer
Written by
otonal
To view profiles and participate in discussions please or .
3 Replies
•
AussieNeilAdministrator
Excellent points - surely policy makers need to know the TOTAL lifetime costs of all available options so the best decisions are possible?
For CLL, that approach would also highlight the dire need for more research and clinical trials into ways to reduce the impact of CLL and CLL treatments on our immunity.
NeIl
So many issues go into cost/benefit analysis. Make my head spin. Is Ibrutinib a bargain because I am not hospitalized?...
Virginia
Not what you're looking for?
You may also like...
Chicken link to blood cancer
leave it and if it helps just one person, then it’s worth it.
I can only add one photo to a post...
Pfizer Vaccine and Blood Cancer
window for cancer patients, and particularly for blood cancer,...
COVID, Pneumonia and healthcare
recent experience with COVID-19, pneumonia, and healthcare. I tested positive for COVID 20 days ago...
Blood cancers debate in UK Parliament - CLL highlighted
fairer access for patients with blood cancers (rarer cancers).
You can read the full debate here:...